Answers are grounded in this paper and cite their sources.
Selective degeneration of nigrostriatal dopaminergic neurons is a hallmark of Parkinson’s disease (PD), but the mechanisms linking mitochondrial oxidative stress to dopaminergic neuronal vulnerability remain incompletely understood.¹ Dopaminergic neurons exhibit distinctive physiological and metabolic characteristics, including a high oxidative burden and substantial dependence on mitochondrial function, that may contribute to their vulnerability in PD. 1 Peroxiredoxin 3 (Prdx3) is a mitochondrial matrix peroxidase and major peroxide scavenger that contributes to mitochondrial redox homeostasis. 2 Previous work has shown that PRDX3 gene delivery can protect dopaminergic neurons in a toxin-based PD model, 3 but how endogenous Prdx3 deficiency affects age-dependent nigrostriatal integrity in vivo remains incompletely defined. Here, using constitutive Prdx3 knockout (KO) mice, we show that Prdx3 deficiency is associated with progressive dopaminergic neurodegeneration, mitochondrial redox abnormalities, and age-dependent accumulation of oxidized dopamine-associated fluorescence.
No takes yet. Share an insight, caveat, or question.
Sonn et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: